TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Lab Pharma AS
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
19,471
|
15,351
|
16,331 |
| Financial expenses |
922
|
353
|
772 |
| Earnings before taxes |
1,404
|
-598
|
-854 |
| Total assets |
5,948
|
3,366
|
3,514 |
| Current assets |
4,581
|
1,602
|
1,780 |
| Current liabilities |
4,841
|
3,353
|
3,008 |
| Equity capital |
1,107
|
13
|
506 |
| - share capital |
332
|
353
|
373 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
18.6%
|
0.4%
|
14.4% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
7.2%
|
-3.9%
|
-5.2% |
| Return on assets (ROA) |
39.1%
|
-7.3%
|
-2.3% |
| Current ratio |
94.6%
|
47.8%
|
59.2% |
| Return on equity (ROE) |
126.8%
|
-4600%
|
-168.8% |
| Change turnover |
5,064
|
-122
|
-7,945 |
| Change turnover % |
35%
|
-1%
|
-33% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.